Top MTP Kit Brands: Reliable Choices for Safe Outcomes

In the realm of reproductive health, the choice of a reliable MTP (Medical Termination of Pregnancy) kit is of paramount importance for safely managing an unplanned pregnancy. With various options available in the market, selecting a brand renowned for its efficacy and safety can significantly impact the user's experience. Each brand differs in terms of formulation, packaging, and instructions, yet all aim to provide a safe and effective solution. To explore an encompassing list of the best MTP kit brands, continue reading below.

Illustration of mtp kit

Best brands of mtp kit in 2025

Cipla

Cipla, a leading pharmaceutical company, is renowned for producing high-quality MTP kits, which are essential for medical abortions. Established in 1935, Cipla has a strong commitment to making medicines accessible and affordable, with a presence in over 80 countries and a portfolio of 1,500+ generic products. The MTP Kit by Cipla, which includes one Mifepristone tablet and four Misoprostol tablets, is a trusted option in India and other markets. Cipla's respiratory portfolio, among other therapeutic segments, continues to hold a significant market share, with 55% of its commercial portfolio ranking top 3 in market share. The company's innovative approach and focus on quality have made it a global leader in the pharmaceutical industry. For more information, visit Cipla's official website.

Sun Pharma

Sun Pharmaceutical Industries Limited, one of the world's leading generic pharmaceutical companies, is renowned for its high-quality medications, including the MTP (Medical Termination of Pregnancy) kit. Sun Pharma's MTP kit, such as Sunmedabon, combines mifepristone and misoprostol, and has been granted marketing authorization in several regions due to its stringent quality, safety, and efficacy standards. The company invests up to 6-8% of its global revenues in research and development, ensuring the production of technologically complex and reliable products. With a global presence in over 100 countries and a strong market share in India, Sun Pharma is a trusted name in the pharmaceutical industry. Its commitment to quality control and stability studies under International Conference of Harmonisation (ICH) conditions further solidifies its reputation.

Mankind Pharma

Mankind Pharma is a leading pharmaceutical company in India, renowned for its diverse range of products, including the MTP (Medical Termination of Pregnancy) kit. As the fourth largest pharmaceutical company in India, Mankind Pharma has a significant market share, with over 4.4% of the Indian Pharmaceutical Market (IPM) and more than 38 brands ranking in the top-5 in their therapy categories. The company's MTP kit, such as the Unwanted Kit, is a key product in its portfolio, contributing to its strong presence in the market. In FY22, Mankind Pharma was the most prescribed pharma company in the IPM, with around 15.3% of prescriptions, and it claims that about 80% of doctors in India prescribe its medicines. The company's integrated manufacturing capabilities, with 23 plants across India, further enhance its production and distribution efficiency. For more detailed information, please visit Mankind Pharma’s official website.

Zydus Cadila

Zydus Cadila is a renowned pharmaceutical company that produces high-quality Medical Termination of Pregnancy (MTP) kits, such as the Mifegest Kit, which includes one Mifepristone tablet and four Misoprostol tablets. This kit is part of the company's commitment to women's healthcare, offering a safe and effective method for early-stage pregnancy termination. Zydus Cadila has a long history of innovation, established in 1952, and has expanded its product range significantly over the years. The company's MTP kits are widely used and trusted, contributing to its strong presence in the Indian pharmaceutical market. With its extensive experience and regulatory approvals, Zydus Cadila continues to be a reliable producer of essential medical products. For more information about the pill price, visit Pristyn Care.

Abbott

Abbott is a leading producer in the pregnancy test kits market, known for its high-quality products and significant market presence. The company is part of a highly competitive landscape, with North America dominating the market, where Abbott has a strong foothold, contributing to the region's nearly 33% market share in 2022. Abbott's products, along with those of other key players like Church & Dwight and SPD Swiss Precision Diagnostics GmbH, drive the market growth with a CAGR of 5.08% from 2022 to 2028. The global pregnancy test kits market, valued at USD 1.70 billion in 2022, is expected to reach USD 2.28 billion by 2028, with Abbott playing a crucial role in this expansion. The company's focus on technological advancements and broad distribution networks enhances its market penetration.

Lupin

Lupin Limited is a prominent player in the pharmaceutical industry, particularly noted for its significant presence in the market for Medical Termination of Pregnancy (MTP) kits, which include mifepristone and misoprostol. As of the financial year 2020, Lupin had a coverage of over 76% in the Indian pharmaceutical market, showcasing its dominance. The company's robust performance is highlighted by its record-high quarterly sales and comprehensive growth across regions, including a strong U.S. business and impressive growth in the Indian market. Lupin's product mix and regional expansion have fueled its profitability, making it a reliable producer for essential medicines like MTP kits. The company's commitment to quality and compliance ensures that its products meet stringent regulatory standards. For more details about Lupin's innovative solutions, visit their official website.

Glenmark

Glenmark Pharmaceuticals is renowned for its robust presence in the pharmaceutical industry, particularly in the production of the MTP (Medical Termination of Pregnancy) kit. As of recent financial reports, Glenmark's India business has shown significant growth, with a market share of 2.16% in the Indian pharmaceutical market as per IQVIA MAT March 2024. The company's strong performance in key therapy areas, including a ranking of 2nd in both the Respiratory and Dermatology segments, underscores its commitment to quality and innovation. Glenmark's successful product launches, such as Remogliflozin and RYALTRIS(r), have garnered positive responses and contributed to the company's growth trajectory. With a history of launching novel and globally-researched products, Glenmark continues to be a trusted name in the pharmaceutical sector. For more information, visit their official website.

Intas Pharmaceuticals

Intas Pharmaceuticals is a leading multinational pharmaceutical company renowned for its comprehensive product portfolio, including the MTP (Medical Termination of Pregnancy) kit. With a strong presence in over 85 countries, Intas has achieved significant market share, particularly in highly regulated markets like the EU and US, where around 70% of its revenues are generated. The company operates 14 formulation manufacturing facilities globally, ensuring high-quality products that meet international regulatory standards. Intas has a robust R&D focus, investing around 6-7% of its turnover in research and development annually. Its strategic business model and diversified product basket have enabled the company to grow at a CAGR of approximately 22%.

Torrent Pharmaceuticals

Torrent Pharmaceuticals is a leading pharmaceutical company, renowned for its robust presence in various therapeutic segments, including cardiovascular, central nervous system, gastro-intestinal, and women's healthcare. While it is not specifically highlighted as a producer of MTP (Medical Termination of Pregnancy) kits, the company's strong market position and consistent growth, such as an 18% revenue increase in Q3 FY23 and a market capitalization crossing $10 billion, underscore its capabilities in the pharmaceutical industry. Torrent Pharma's significant R&D investments and international accreditations, including USFDA approvals for four of its manufacturing facilities, further solidify its reputation. The company's expansion, including the integration of Curatio Healthcare, has enhanced its market share and product portfolio. For more detailed information about their operations and products, visit their official website. However, specific data on MTP kits is not provided in the available sources.

Dr. Reddy's Laboratories

Dr. Reddy's Laboratories is a leading producer of pharmaceutical products, including the MTP (Medical Termination of Pregnancy) kit, known for its high quality and affordability. The company has a significant presence in the Indian pharmaceutical market, with a covered market share of over 48% as of FY 2020. Dr. Reddy's has a strong track record of innovation and expansion, with revenues growing by 19% in North America and 19% in India in FY 2016, driven by successful product launches and market share gains. The company's commitment to accessible healthcare is evident in its extensive product portfolio, which includes a variety of therapeutic categories such as gastrointestinal, cardiovascular, and dermatology. Dr. Reddy's continues to invest in R&D, with a focus on biosimilar products and new drug applications, ensuring a robust pipeline of future medications. For more information, visit their official website.